Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Healthcare | Large Cap
Health Score : 6.29Apollo Hospitals demonstrates a mixed financial performance. Strong growth in revenue, operating profit, and earnings per share indicates positive market traction and efficient operations. The company also shows good solvency, supported by a healthy equity ratio. However, liquidity appears weak, suggesting potential challenges in meeting short-term obligations. While profitability metrics like gross profit margin, ROCE, and ROA are robust, certain financial aspects such as adjusted EPS and net margin need improvement. The company's efficiency is also a concern, particularly in asset turnover. Overall, Apollo Hospitals exhibits growth potential and solid profitability, but needs to address its liquidity and efficiency to ensure long-term financial stability.
Health Score : 6.29Apollo Hospitals demonstrates a mixed financial performance. Strong growth in revenue, operating profit, and earnings per share indicates positive market traction and efficient operations. The company also shows good solvency, supported by a healthy equity ratio. However, liquidity appears weak, suggesting potential challenges in meeting short-term obligations. While profitability metrics like gross profit margin, ROCE, and ROA are robust, certain financial aspects such as adjusted EPS and net margin need improvement. The company's efficiency is also a concern, particularly in asset turnover. Overall, Apollo Hospitals exhibits growth potential and solid profitability, but needs to address its liquidity and efficiency to ensure long-term financial stability.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
84.34
Industry Median
53.17
Large Cap Median
64.83
P/E RATIO
64.83
P/B RATIO
13.29
Industry Median
5.27
Large Cap Median
13.29
P/S RATIO
4.95
Industry Median
3.91
Large Cap Median
4.95
Others
PEG RATIO
0.91
EV/EBITDA RATIO
32.35
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹8755 as on Sep 1, 2026.
Growth Score : 8.00The company shows strong growth trends across key metrics. High growth scores in revenue, operating profit, and earnings per share indicate successful market strategies and operational improvements. However, the fact that Net income growth rate is low indicates that some part of profits are not being reinvested back into the company. Overall, the company's growth trajectory suggests a positive outlook, but continued attention to profitability and asset management is essential.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 38.85 | 13.29 | 14.73 | 14.35 | 15.76 |
| Operating Profit Growth Rate | 92.02 | -5.66 | 15.93 | 26.69 | 24.27 |
| Earnings Per Share (EPS) Growth | 601.91 | -22.41 | 9.71 | 60.9 | 34.29 |
| Asset Growth Rate | 16.41 | 8.71 | 16.13 | 23.31 | 7.52 |
| Net Income Growth Rate | 708.76 | -23.83 | 10.78 | 60.96 | 33.09 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Fortis Healthcare Ltd | 6.50 | 66.30 | Neutral | 2085.00 | 3.05 | 1064.00 |
| 2 | Apollo Hospitals Enterprise Ltd | 6.29 | 64.83 | Neutral | 3769.00 | 103.81 | 2003.00 |
| 3 | Max Healthcare Institute Ltd | 5.61 | 67.68 | Neutral | 2243.00 | 7.36 | 1442.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤7th Nov 25
Q2 & H1 FY26 Earnings Conference Call
NEUTRAL SENTIMENT
Apollo Hospitals Enterprise Ltd is a leading integrated healthcare provider in India, operating over 70 hospitals, a vast network of pharmacies, primary care clinics, and digital health platforms. It offers comprehensive medical services, diagnostics, and wellness solutions, establishing itself as a pioneer and market leader in quality healthcare delivery.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Apollo Hospitals Enterprise Ltd's P/E ratio (TTM) is 84.34, compared to the industry median of 53.17 and large cap median of 64.83.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Apollo Hospitals Enterprise Ltd's P/B ratio is 13.29, compared to the industry median of 5.27 and large cap median of 13.29.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Apollo Hospitals Enterprise Ltd's P/S ratio is 4.95, compared to the industry median of 3.91 and large cap median of 4.95.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Apollo Hospitals Enterprise Ltd's PEG ratio is 0.91.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Apollo Hospitals Enterprise Ltd's EV/EBITDA ratio is 32.35.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Apollo Hospitals Enterprise Ltd's ROE is 21.13%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Apollo Hospitals Enterprise Ltd's ROA is 16.98%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Apollo Hospitals Enterprise Ltd's ROCE is 18%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Apollo Hospitals Enterprise Ltd's operating margin is 14.94%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Apollo Hospitals Enterprise Ltd's net margin is 7.94%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Apollo Hospitals Enterprise Ltd's current ratio is 0.90.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Apollo Hospitals Enterprise Ltd's debt-to-equity ratio is 0.56.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Apollo Hospitals Enterprise Ltd's interest coverage ratio is 6.91.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Apollo Hospitals Enterprise Ltd's DPS is ₹20.26.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Apollo Hospitals Enterprise Ltd's EPS is 34.29.
(Source line: "Ratios as of 10 Oct 2026, based on last traded price of ₹8755. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1983
Headquarters: Chennai, Tamil Nadu
Core Offerings: Tertiary & Quaternary Hospitals, Retail Pharmacies, Primary Care Clinics, Digital Healthcare (Teleconsultation, E-pharmacy, Diagnostics), Health Insurance
Stock Listing: NSE (APOLLOHOSP), BSE (508869)
Promoter: Dr. Prathap C Reddy & Family
1983: Founded by Dr. Prathap C Reddy, opening India's first corporate hospital in Chennai. 1996: Launched Apollo Pharmacy, pioneering organized retail pharmacy in India. 2007: Established Apollo Clinics for primary healthcare services. 2020: Launched Apollo 24/7, its integrated digital health platform for online consultations, pharmacy, and diagnostics. Present: Operates as one of Asia's largest integrated healthcare providers, continually expanding its reach and services.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Healthcare Services (Hospitals) | 51% | 24.3% margin |
| Apollo HealthCo (Pharmacies, Digital & Diagnostics) | 38% | 7.9% margin |
| Others (Clinics, Insurance, etc.) | 11% | Operating Profit |
Healthcare Services (Hospitals): Operates a network of 70+ hospitals across India, offering multi-specialty and super-specialty tertiary and quaternary care in cardiology, oncology, orthopedics, organ transplants, and more, serving over 15 million patients annually.
Apollo HealthCo (Pharmacies, Digital & Diagnostics): Encompasses Apollo Pharmacy, India's largest retail pharmacy chain with over 5,700 stores, along with the integrated digital health platform Apollo 24/7 (teleconsultations, online pharmacy, diagnostic services), and primary care clinics.
Dr. Prathap C Reddy, Founder & Chairman: A visionary physician and entrepreneur, he is credited with establishing India's first corporate hospital and pioneering modern private healthcare in the country.
Apollo Health and Lifestyle Limited
Apollo Pharmacies Limited
Apollo Hospitals International Limited
Apollo Home Healthcare Limited
2021: Demerger of the pharmacy and digital health businesses into Apollo HealthCo Limited (a subsidiary), aimed at unlocking value and driving focused growth in these segments.
The Apollo Hospitals Enterprise Ltd share price today is ₹8755 on NSE (APOLLOHOSP), as of 12 Oct 2026.
As of 10 Oct 2026, Apollo Hospitals Enterprise Ltd share price is ₹8755, with previous close ₹8755. Today's range is ₹8755 to ₹8755. The 52-week range is ₹6696.50 to ₹9070.50.
As of today, Apollo Hospitals Enterprise Ltd's market cap is ₹1,24,846.3 crore (Large Cap).
Apollo Hospitals Enterprise Ltd's current P/E ratio is 84.34, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 45.
Apollo Hospitals Enterprise Ltd's current P/B ratio is 13.29.
Apollo Hospitals Enterprise Ltd's current dividend yield is 0.23%. Last dividend of ₹6.00 per share was declared on 24-May-2024.
Apollo Hospitals Enterprise Ltd's EPS (TTM) is ₹34.29.
Apollo Hospitals Enterprise Ltd is a leading integrated healthcare provider in India, operating over 70 hospitals, a vast network of pharmacies, primary care clinics, and digital health platforms. It offers comprehensive medical services, diagnostics, and wellness solutions, establishing itself as a pioneer and market leader in quality healthcare delivery.
Apollo Hospitals Enterprise Ltd is promoted by Dr. Prathap C Reddy & Family, holding 28.02% as of 10 Oct 2026.
Apollo Hospitals Enterprise Ltd is listed on NSE (APOLLOHOSP) and BSE (508869). Its next quarterly results are expected on August 2024.
